Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

COVAX

- PMLiVE

Relief Therapeutics seeks US emergency approval for COVID-19 drug

If granted, EUA would give approval for use in severely ill patients with no other treatment options

- PMLiVE

BioNTech bolsters COVID-19 vaccine capacity with Novartis deal

Deal will expand production capacity for BNT162b2 candidate

- PMLiVE

Moderna inks R&D agreements with Vertex and Chiesi

Biotech agrees to separate deals for the development of gene-editing and mRNA therapies

- PMLiVE

Sanofi, GSK to launch human trials of COVID-19 vaccine

Vaccine combines Sanofi’s baculovirus expression system and GSK’s AS03 adjuvant

- PMLiVE

Regeneron launches phase 3 COVID-19 antibody trial in the UK

Drug cocktail will be evaluated in patients hospitalised with COVID-19

AstraZeneca AZ

AZ pauses COVID-19 vaccine study after participant falls ill

Serious adverse event puts clinical programme on hold

- PMLiVE

RedHill Biopharma’s SK2 inhibitor shows promise against coronavirus

Opaganib demonstrate potent inhibition of SARS-CoV-2 in an in vitro test

- PMLiVE

Top biopharma CEOs sign COVID-19 vaccine safety pledge

Leaders promise to uphold rigorous safety and efficacy protocols

- PMLiVE

First patients dosed with COVID-19 vaccine from SpyBiotech and Serum Institute of India

Candidate uses similar technology from a licensed Hepatitis B vaccine

- PMLiVE

Sinovac’s COVID-19 vaccine appears safe in older adults

But immune responses were not as effective as those in younger adults

- PMLiVE

Positive COPD data for Synairgen’s SNG001 supports COVID-19 programme

UK biotech says data is encouraging for separate trial programme in COVID-19

- PMLiVE

Widespread COVID-19 vaccinations not expected until mid-2021, says WHO

Potential candidates must prove robust efficacy and safety first

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links